219 related articles for article (PubMed ID: 18945760)
1. Control of the papillomavirus early-to-late switch by differentially expressed SRp20.
Jia R; Liu X; Tao M; Kruhlak M; Guo M; Meyers C; Baker CC; Zheng ZM
J Virol; 2009 Jan; 83(1):167-80. PubMed ID: 18945760
[TBL] [Abstract][Full Text] [Related]
2. Utilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3' splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element.
Zheng ZM; Reid ES; Baker CC
J Virol; 2000 Nov; 74(22):10612-22. PubMed ID: 11044105
[TBL] [Abstract][Full Text] [Related]
3. Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes.
Klymenko T; Hernandez-Lopez H; MacDonald AI; Bodily JM; Graham SV
J Virol; 2016 May; 90(10):5047-58. PubMed ID: 26962216
[TBL] [Abstract][Full Text] [Related]
4. Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.
Li X; Johansson C; Cardoso Palacios C; Mossberg A; Dhanjal S; Bergvall M; Schwartz S
PLoS One; 2013; 8(9):e72776. PubMed ID: 24039800
[TBL] [Abstract][Full Text] [Related]
5. Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome.
Somberg M; Schwartz S
J Virol; 2010 Aug; 84(16):8219-30. PubMed ID: 20519389
[TBL] [Abstract][Full Text] [Related]
6. Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters.
Barksdale SK; Baker CC
J Virol; 1993 Sep; 67(9):5605-16. PubMed ID: 8394463
[TBL] [Abstract][Full Text] [Related]
7. Differentiation-specific alternative splicing of bovine papillomavirus late mRNAs.
Barksdale S; Baker CC
J Virol; 1995 Oct; 69(10):6553-6. PubMed ID: 7666558
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus E4orf4 induces HPV-16 late L1 mRNA production.
Somberg M; Rush M; Fay J; Ryan F; Lambkin H; Akusjärvi G; Schwartz S
Virology; 2009 Jan; 383(2):279-90. PubMed ID: 19026433
[TBL] [Abstract][Full Text] [Related]
9. Papillomavirus transcripts and posttranscriptional regulation.
Schwartz S
Virology; 2013 Oct; 445(1-2):187-96. PubMed ID: 23706315
[TBL] [Abstract][Full Text] [Related]
10. The HPV-16 E7 oncoprotein is expressed mainly from the unspliced E6/E7 transcript in cervical carcinoma C33-A cells.
del Moral-Hernández O; López-Urrutia E; Bonilla-Moreno R; Martínez-Salazar M; Arechaga-Ocampo E; Berumen J; Villegas-Sepúlveda N
Arch Virol; 2010 Dec; 155(12):1959-70. PubMed ID: 20865289
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.
Dhanjal S; Kajitani N; Glahder J; Mossberg AK; Johansson C; Schwartz S
J Biol Chem; 2015 May; 290(21):13354-71. PubMed ID: 25878250
[TBL] [Abstract][Full Text] [Related]
12. Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs.
Li X; Johansson C; Glahder J; Mossberg AK; Schwartz S
Nucleic Acids Res; 2013 Dec; 41(22):10488-508. PubMed ID: 24013563
[TBL] [Abstract][Full Text] [Related]
13. Optimization of a weak 3' splice site counteracts the function of a bovine papillomavirus type 1 exonic splicing suppressor in vitro and in vivo.
Zheng ZM; Quintero J; Reid ES; Gocke C; Baker CC
J Virol; 2000 Jul; 74(13):5902-10. PubMed ID: 10846071
[TBL] [Abstract][Full Text] [Related]
14. RNA splicing factors regulated by HPV16 during cervical tumour progression.
Mole S; McFarlane M; Chuen-Im T; Milligan SG; Millan D; Graham SV
J Pathol; 2009 Nov; 219(3):383-91. PubMed ID: 19718710
[TBL] [Abstract][Full Text] [Related]
15. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.
Zhao X; Rush M; Schwartz S
J Virol; 2004 Oct; 78(20):10888-905. PubMed ID: 15452209
[TBL] [Abstract][Full Text] [Related]
16. Serine/arginine-rich protein 30c activates human papillomavirus type 16 L1 mRNA expression via a bimodal mechanism.
Somberg M; Li X; Johansson C; Orru B; Chang R; Rush M; Fay J; Ryan F; Schwartz S
J Gen Virol; 2011 Oct; 92(Pt 10):2411-2421. PubMed ID: 21697349
[TBL] [Abstract][Full Text] [Related]
17. Viral DNA Replication Orientation and hnRNPs Regulate Transcription of the Human Papillomavirus 18 Late Promoter.
Wang X; Liu H; Ge H; Ajiro M; Sharma NR; Meyers C; Morozov P; Tuschl T; Klar A; Court D; Zheng ZM
mBio; 2017 May; 8(3):. PubMed ID: 28559488
[TBL] [Abstract][Full Text] [Related]
18. hnRNP L controls HPV16 RNA polyadenylation and splicing in an Akt kinase-dependent manner.
Kajitani N; Glahder J; Wu C; Yu H; Nilsson K; Schwartz S
Nucleic Acids Res; 2017 Sep; 45(16):9654-9678. PubMed ID: 28934469
[TBL] [Abstract][Full Text] [Related]
19. Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632.
Somberg M; Zhao X; Fröhlich M; Evander M; Schwartz S
J Virol; 2008 Apr; 82(7):3665-78. PubMed ID: 18216120
[TBL] [Abstract][Full Text] [Related]
20. An element in the bovine papillomavirus late 3' untranslated region reduces polyadenylated cytoplasmic RNA levels.
Furth PA; Baker CC
J Virol; 1991 Nov; 65(11):5806-12. PubMed ID: 1717710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
